Track PDUFA dates, clinical trial results, and FDA decisions for biotech stocks. Free, comprehensive, and always up-to-date.
The next big biotech events
CTX001 Phase 3 Results Expected
Vertex Pharmaceuticals Incorporated
XEN1101 Phase 3 Results Expected
Xenon Pharmaceuticals Inc.
KB801 Phase 2 Results Expected
Krystal Biotech, Inc.
Ratutrelvir (83-0060) non-randomised Phase 2 Results Expected
Traws Pharma, Inc.
Ixekizumab Phase 3 Results Expected
Eli Lilly and Company
Comprehensive biotech catalyst tracking designed for retail investors
Data synced daily from ClinicalTrials.gov, SEC filings, and FDA announcements
All data comes directly from government databases and official company filings
Full access without signup. No email, no credit card, no tracking
Start exploring upcoming biotech events and never miss an important catalyst again.
